Issuer Information

EDGAR: Contact Information
  • Name:
    Quince Therapeutics, Inc.
  • Address:
    611 GATEWAY BLVD., SUITE 273
    SOUTH SAN FRANCISCO, CALIFORNIA 94080
  • Phone:
    (415) 910-5717
EDGAR: Other Information
  • Jurisdiction:
    CALIFORNIA
  • Entity Type:
    Corporation
  • Incorporated:
    Over 5 years ago
  • Previous Names:
    Cortexyme, Inc.

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
560457: 0001662774-25-000035
First Sale: 2025-06-18
Security Type(s): Equity
Offer Amount: $21,896,618
Amount Sold: $11,488,304
Remaining: $10,408,314
06b

CA, CT, DE, NC, NV, NY, PA, TN, TX,

265312: 0001662774-18-000001
First Sale: 2018-05-23
Security Type(s): Equity
Offer Amount: $85,566,697
Amount Sold: $84,466,700
Remaining: $1,099,997
06b

CA, ID, VA,

232365: 0001662774-17-000001
First Sale: 2017-02-01
Security Type(s): Debt
Offer Amount: $8,000,000
Amount Sold: $7,600,000
Remaining: $400,000
06b

CA,

156229: 0001662774-16-000002
First Sale: 2015-12-22
Security Type(s): Equity
Offer Amount: $15,918,641
Amount Sold: $7,918,642
Remaining: $7,999,999
06b No Notices in EFD for this offering.

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.